Angiex, Inc. — Form D
Angiex, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-17. The offering totals $3.0M, of which $2.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-07-17
- Form: D
- Accession: 0001710380-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.9M
- Remaining: $120K
- Investors: 3
- Date of first sale: 2017-07-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-290865
Issuer
- Name: Angiex, Inc.
- CIK: 0001710380
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 150 Cambridge Park Drive, 5th Floor, CAMBRIDGE, MA, 02140
- Phone: 617-576-1753
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Jonathan Adams | Director | Philadelphia, PA |
| Errik Anderson | Director | Cambridge, MA |
| Jason Camm | Director | WALTHAM, MA |
| Fabian Hansen | Director | Cambridge, MA |
| Paul Jaminet | Director | Cambridge, MA |
| Paul Jaminet | Executive Officer | Cambridge, MA |
| Amal Amin | Director | Cambridge, MA |
| Haijing Guo | Director | Cambridge, MA |
| Iain Dukes | Director | Cambridge, MA |
| Tina Neel | Director | Cambridge, MA |
Other filings by this issuer (2)
More